Borja Cembrero - Jun 4, 2025 Form 4 Insider Report for My Size, Inc. (MYSZ)

Signature
/s/ Borja Cembrero
Stock symbol
MYSZ
Transactions as of
Jun 4, 2025
Transactions value $
$0
Form type
4
Date filed
6/6/2025, 04:10 PM
Previous filing
May 28, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Cembrero Saralegui Borja Chief Growth Officer C/O MY SIZE INC., HANEGEV 4, POB 1026, AIRPORT CITY, ISRAEL /s/ Borja Cembrero 2025-06-06 0002067690

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MYSZ Option to purchase Common Stock (right to buy) Disposed to Issuer -1.69K -100% 0 Jun 4, 2025 Common Stock, $.001 par value per share 1.69K $8.72 Direct F1, F3
transaction MYSZ Option to purchase Common Stock (right to buy) Award +1.69K 1.69K Jun 4, 2025 Common Stock, $.001 par value per share 1.69K $1.28 Direct F1, F3
transaction MYSZ Option to purchase Common Stock (right to buy) Disposed to Issuer -2.5K -100% 0 Jun 4, 2025 Common Stock, $.001 par value per share 2.5K $3.83 Direct F2, F3
transaction MYSZ Option to purchase Common Stock (right to buy) Award +2.5K 2.5K Jun 4, 2025 Common Stock, $.001 par value per share 2.5K $1.28 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted under the My Size, Inc. 2017 Equity Incentive Plan and vest and become exercisable in three equal installments, with 1/3 vesting on each of July 13, 2024, July 13, 2025 and July 13, 2026, subject to the Reporting Person's continued service.
F2 The options were granted under the My Size, Inc. 2017 Equity Incentive Plan and vest and become exercisable in three equal installments, with 1/3 vesting on each of February 14, 2025, February 14, 2026 and February 14, 2027, subject to the Reporting Person's continued service.
F3 Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged.

Remarks:

On April 23, 2024, the Company implemented a 1-for-8 reverse stock split (the "Reverse Stock Split") of the Company's common stock. All amounts have been adjusted to give effect to the Reverse Stock Split.